Daisy Woods is a mum of two who has created a space where honesty reigns and motherhood is shared in its rawest, most ...

When India Bolton was diagnosed with psoriasis in college, she didn't expect a progression to psoriatic arthritis to happen so soon.

A clinical diagnosis was made of psoriasis and he was prescribed clobetasol propionate ointment with salicylic acid 6% in petrolatum that should be applied in the evening to his elbows and knees ...

SOLANA BEACH, Calif., April 28, 2025 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop ...

The study assessed the use of the interleukin-23 inhibitor icotrokinra (Protagonist Therapeutics, Johnson & Johnson) in adult and adolescent patients with moderate-to-severe plaque psoriasis.

If you have psoriasis, a chronic condition that primarily affects the skin, you might not know that it can also affect your eyes. But the inflammation that causes lesions on your skin is systemic ...

BMS has previously said it reckons Sotyktu could become a $4 billion seller at its peak, fuelled by head-to-head studies showing it was more effective at treating moderate-to-severe psoriasis than ...

Johnson & Johnson has moved a step closer to filing a potential first-in-class therapy for psoriasis after the drug hit the mark in a phase 3 trial. Once-daily oral IL-23 inhibitor icotrokinra ...

Surprisingly, nearly 10% of adults in the United States experience some form of skin condition affecting the area behind their ears, including ailments such as ear eczema and psoriasis in ears. This ...

The phase 3 study’s week 52 results confirmed consistent pharmacokinetics, efficacy, and safety. As confidence grows, biosimilars will expand treatment access for psoriasis patients.